Filter
622
Filtered Results: 622
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
55
New Publications
192
Language
Document type
No document type
330
Studies & Reports
110
Guidelines
84
Strategic & Response Plan
39
Manuals
37
Training Material
8
Fact sheets
8
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
35
Global
31
Ethiopia
27
Kenya
26
Uganda
16
South Africa
14
Liberia
11
Nepal
11
Tanzania
11
Western and Central Europe
11
Sierra Leone
10
Nigeria
10
Zambia
9
Namibia
9
Ghana
8
Philippines
8
Rwanda
7
Bangladesh
7
Ukraine
7
Zimbabwe
6
Indonesia
6
Africa
6
South Sudan
5
Syria
5
Myanmar / Burma
5
Congo, Democratic Republic of
4
Cambodia
4
Malawi
4
Lesotho
4
Eastern Europe and Central Asia
4
Senegal
3
Cameroon
3
Eswatini/ Swaziland
3
West and Central Africa
3
South–East Asia Region
3
Eastern Europe
3
Burkina Faso
2
Pakistan
2
Jordan
2
Thailand
2
Mozambique
2
Botswana
2
East and Southern Africa
2
Latin America and the Carribbean
2
Fiji
2
Laos
2
Vietnam
2
Guinea
1
Mali
1
USA
1
Haiti
1
Somalia
1
Iraq
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Libya
1
Yemen
1
Middle East and North Africa
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Iran
1
Australia
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
35
Key Resources
31
Public Health
29
Women & Child Health
17
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
56
AMR
50
COVID-19
30
HIV
29
Mental Health
28
Planetary Health
27
TB
26
NTDs
25
Rapid Response
17
Conflict
13
NCDs
12
Health Financing Toolbox
11
Caregiver
10
Ebola
9
Global Health Education
8
Specific Hazards
6
Disability
4
Natural Hazards
3
Refugee
3
Social Ethics
2
Health Financing
2
South Sudan
1
Zika
1
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Assessment Report
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast cancer. Due
to limited access to prevention, early dia...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
